Flputnam Investment Management Co. purchased a new position in Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 18,265 shares of the conglomerate’s stock, valued at approximately $13,152,000.
Several other institutional investors and hedge funds have also bought and sold shares of the company. High Note Wealth LLC increased its position in Danaher by 19.2% in the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after buying an additional 47 shares during the last quarter. First Command Advisory Services Inc. lifted its position in shares of Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after buying an additional 47 shares during the last quarter. GW&K Investment Management LLC grew its stake in shares of Danaher by 8.4% during the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after acquiring an additional 47 shares during the period. Kestra Private Wealth Services LLC increased its holdings in Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after acquiring an additional 48 shares during the last quarter. Finally, SOL Capital Management CO increased its holdings in Danaher by 2.7% in the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock worth $430,000 after acquiring an additional 50 shares during the last quarter. 79.05% of the stock is owned by institutional investors.
Danaher Price Performance
Shares of NYSE:DHR opened at $202.51 on Monday. The company has a 50 day moving average of $193.14 and a 200 day moving average of $192.91. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market cap of $142.37 billion, a P/E ratio of 35.97, a P/E/G ratio of 2.52 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.
Wall Street Analyst Weigh In
DHR has been the topic of several recent research reports. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Morgan Stanley reduced their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. lowered their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Piper Sandler started coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Finally, TD Cowen cut their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $228.91.
Check Out Our Latest Stock Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
